2026 is set to be a pivotal year for AI in pharmaceuticals, as AI-powered simulations and richer data are expected to reshape clinical trial design, improving efficiency and data quality.

The pharmaceutical industry is poised for a paradigm shift from Research & Development (R&D) to Research & Prediction (R&P), with agentic AI expected to deliver the first fully predictive drug development pipeline by 2026.